Comparative safety and immunogenicity trial of two killed Leishmania Major vaccines with or without BCG in human volunteers
about
Vaccines for preventing cutaneous leishmaniasisVaccines to prevent leishmaniasis.The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models.Overview of dendritic cell-based vaccine development for leishmaniasis.Subcutaneous immunization against Leishmania major - infection in mice: efficacy of formalin-killed promastigotes combined with adjuvants.Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial.Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection.Cloning, expression and dynamic simulation of TRYP6 from Leishmania major (MRHO/IR/75/ER).Caffeic acid combined with autoclaved Leishmania major boosted the protection of infected BALB/c mice by enhancing IgG2 production, IFN-γ/TGF-β and iNO synthase/arginase1 ratios, and the death of infected phagocytes.Cytokine Gene Expression in Healing and Non-Healing Cases of Cutaneous Leishmaniasis in Response to In vitro Stimulation with Recombinant gp63 Using Semi-Quantitative RT-PCR
P2860
Q24240664-C47E4376-F480-4C5E-A6A0-164B7DFC9920Q34511559-8079388D-37E4-4481-91CA-3406FC05565CQ36599857-B6356C31-4DD9-44F4-94A4-854036FC00C0Q38887861-EA308EAC-1724-4FB5-8A9A-833797B45FA7Q39284820-BE0B693F-76D2-4755-B42F-19A615683756Q39566759-C47E6FB3-E658-4D66-B845-F71F4E285ED6Q42477181-CA9A643F-93FB-4090-BD26-857DC47AD180Q43523348-518AD9EA-4498-48FC-9C53-6577A77C6DA3Q46878999-98D83261-5388-4DD9-A17F-6E494DDAB3CCQ58485935-1C298D1F-D4EF-494A-88B7-8347C5C38062
P2860
Comparative safety and immunogenicity trial of two killed Leishmania Major vaccines with or without BCG in human volunteers
description
im September 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 September 1996
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 1996
@uk
name
Comparative safety and immunog ...... ithout BCG in human volunteers
@en
Comparative safety and immunog ...... ithout BCG in human volunteers
@nl
type
label
Comparative safety and immunog ...... ithout BCG in human volunteers
@en
Comparative safety and immunog ...... ithout BCG in human volunteers
@nl
prefLabel
Comparative safety and immunog ...... ithout BCG in human volunteers
@en
Comparative safety and immunog ...... ithout BCG in human volunteers
@nl
P2093
P1476
Comparative safety and immunog ...... ithout BCG in human volunteers
@en
P2093
A Khamesipour
F Modabber
R Hashemi-Fesharki
S Ale-Agha
P304
P356
10.1016/0738-081X(96)00071-5
P577
1996-09-01T00:00:00Z